2022.07 Global Times:COVID-19 testing firms report mixed revenues in H1 2022
A number of listed Chinese COVID-19 prevention related companies recently announced their financial results for the first half of 2022, revealing mixed results amid a complicated epidemic landscape. Andon Health Co received Emergency Use Authorization (EUA) from the US Food &Drug Administration (FDA) in November 2021, which allowed its products to be procured by the US government agencies.The FDA's authorization carried no strict technical requirements, so Andon's boost in revenue may not last for a long period, analysts of iiMedia Research Institute,told the Global Times on Sunday.